TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

126.90$ +1.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

GRAIL, LLC (GRAL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,844 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GRAL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 4,557 4,747 3,270 3,118 2,983 2,848 2,703 2,601 2,922 2,803 2,844
– 156 1,033 1,019 910 820 728 652 589 954 877 915
– 97 974 959 854 214 134 127 127 250 69 56
– 97 974 959 854 763 675 603 540 904 823 862
– 22 20 19 20 25 19 16 16 18 20 20
– 22 22 26 21 19 19 20 18 16 17 18
– 889 889 0.0 0.0 0.0 – – – – – –
– 2,687 2,653 2,086 2,051 2,017 1,982 1,920 1,885 1,851 1,816 1,781
– 911 756 575 530 480 434 388 361 344 303 301
– 164 107 88 94 77 75 71 77 80 75 84
– 15 14 14 14 13 13 14 14 12 9.9 11
– 20 8.8 16 7.3 4.8 5.8 6.3 3.4 2.1 4.7 7.2
– 3,646 3,991 2,695 2,588 2,503 2,414 2,315 2,240 2,578 2,501 2,543
– -7,776 -8,006 -9,581 -9,706 -9,803 -9,910 -10,024 -10,113 -10,212 -10,305 -10,415
31 31 31 31 32 32 34 35 36 41 41 43

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?